ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Swetha Anandhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9187-7921; OpenAlex author ID A5018812705. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Co-author DOI 10.1038/s41467-024-49189-x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jimin Min · 1 shared paper, 2024 · strength 0.17
- Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x ↗
Padmanee Sharma · 1 shared paper, 2024 · strength 0.17
- Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x ↗
Anirban Maitra · 1 shared paper, 2024 · strength 0.17
- Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.